Chaga-related preparations, compounds, compositions, and methods of manufacturing and using the same.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- ジェロシンス ラボラトリーズインコーポレイテッド
- Filing Date
- 2024-05-01
- Publication Date
- 2026-06-22
AI Technical Summary
Current cancer treatments, particularly those involving mushrooms, face challenges such as low bioavailability of key compounds like betulinic acid, leading to limited therapeutic effectiveness and potential side effects, and there is a need for more effective and less toxic therapeutic approaches for both human and animal cancers.
A functional food or medical formulation is developed by combining a reduced Chaga product and extract with esterification mixtures containing proline, fructose, fatty acids, and Manuka honey, which enhances the bioavailability of betulinic acid and other compounds, forming a pharmaceutical composition for cancer treatment.
The formulation demonstrates improved cytotoxic effects on cancer cells, inducing apoptosis and inhibiting proliferation, with enhanced bioavailability addressing the limitations of betulinic acid, offering a potentially safer and more effective treatment option.
Smart Images

Figure 2026520079000001_ABST